3 ms·
That's actually better than I heard. Since ALK is more generally rare biomarker (as opposed to EGFR) more of the drugs are still in trial. I asked an oncologist
by ghjnut 5y ago
That's actually better than I heard. Since ALK is more generally rare biomarker (as opposed to EGFR) more of the drugs are still in trial. I asked an oncologist friend about costs and she said $11,000/month.
- rootbear 5y agoThe raw cost of Alecensa is around $18,000/month, if I recall correctly. Medicare covers all but $800 of that, once the copays are spent.